Troglitazone inhibits vascular endothelial growth factor-induced angiogenic signaling via suppression of reactive oxygen species production and extracellular signal-regulated kinase phosphorylation in endothelial cells.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples